Adherence to clotting factor treatment among patients with haemophilia A or B

被引：0
|
作者：
Armstrong, P. E. [1 ]
Malone, D. C. [1 ]
Krishnon, S. [2 ]
Wessler, J. [3 ]
机构：
[1] Strateg Therapeut LLC, Tucson, AZ USA
[2] Biogen Idec Inc, Toronto, NS, Canada
[3] Naval Med Ctr, Portsmouth, VA USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：534 / 535
页数：2
相关论文
共 50 条
  • [41] The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in Canada
    Chang, H
    Sher, GD
    Blanchette, VS
    Teitel, JM
    HAEMOPHILIA, 1999, 5 (04) : 247 - 252
  • [42] Physicians' perceptions of adherence to prophylactic clotting factor infusions
    Thornburg, C. D.
    HAEMOPHILIA, 2008, 14 (01) : 25 - 29
  • [43] Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy
    Giampaolo, A.
    Abbonizio, F.
    Puopolo, M.
    Arcieri, R.
    Mannucci, P. M.
    Hassan, H. J.
    TRANSFUSION MEDICINE, 2011, 21 (04) : 280 - 284
  • [44] A survey among patients with haemophilia and inhibitors or their caregivers, seeking treatment in non-haemophilia treatment centres
    Davis, Joanna A.
    Klamroth, Robert
    Benchikh El Fegoun, Soraya
    Habis, Richard
    de Moerloose, Philippe
    HAEMOPHILIA, 2020, 26 (04) : E205 - E208
  • [45] Bleeding patterns and clotting factor concentrates utilisation in haemophilia patients treated at Kamuzu central hospital, Malawi
    Mkwenembera, Francis
    HAEMOPHILIA, 2024, 30 : 44 - 44
  • [46] Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters
    Tuinenburg, A.
    Biere-Rafi, S.
    Peters, M.
    Verhamme, P.
    Peerlinck, K.
    Kruip, M. J. H. A.
    Laros-Van Gorkom, B. A. P.
    Roest, M.
    Meijers, J. C. M.
    Kamphuisen, P. W.
    Schutgens, R. E. G.
    HAEMOPHILIA, 2013, 19 (05) : 744 - 752
  • [47] Ribavirin and interferon-α-2b combination treatment of chronic hepatitis C in patients with haemophilia and other clotting disorders.
    Fried, R
    Meili, E
    Peter, K
    Hartmann, S
    Tsakiris, D
    Fried, C
    Egger, H
    Zanni, M
    Marbet, G
    GASTROENTEROLOGY, 1999, 116 (04) : A1212 - A1212
  • [48] Predictors of non-adherence to prescribed prophylactic clotting-factor treatment regimens among adolescent and young adults with a bleeding disorder
    McLaughlin, John M.
    Witkop, Michelle L.
    Anderson, Terry L.
    Munn, James
    Lambing, Angela
    Tortella, Bartholomew
    HAEMOPHILIA, 2014, 20 : 117 - 117
  • [49] Predictors of non-adherence to prescribed prophylactic clotting-factor treatment regimens among adolescent and young adults with a bleeding disorder
    Witkop, M. L.
    Mclaughlin, M.
    Anderson, T. L.
    Munn, J. E.
    Lambing, A.
    Tortella, B.
    HAEMOPHILIA, 2016, 22 (04) : E245 - E250
  • [50] PREDICTORS OF NON-ADHERENCE TO PRESCRIBED PROPHYLACTIC CLOTTING-FACTOR TREATMENT REGIMENS AMONG ADOLESCENT AND YOUNG ADULTS WITH A BLEEDING DISORDER
    McLaughlin, John M.
    Witkop, Michelle L.
    Anderson, Terry L.
    Munn, James
    Lambing, Angela
    Tortella, Bartholomew
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E89 - E89
12345